The production of raw heparin sodium and fodder protein is to be launched in Brest Oblast in the coming two years, BelTA learned from the Brestmyasomolprom Concern holding company. Such a production will be new to Belarus.
It will be run by a Belarus-China joint venture. The investment agreement was signed by Brestmyasomolprom Concern and a Chinese company that produces heparin. “Heparin is an anticoagulant; it prevents the clotting of blood.
It is used to treat patients with thrombosis, COVID-19, cancer, in cardiovascular surgeries and cosmetology. One kilogram of this product costs $16,000.
Читать на udf.by